US-based biotechnology company BioMarin Pharmaceutical has announced the completion of an underwritten public offering of senior subordinated convertible notes to raise $450m.

The notes carry a rate of 0.599% and are due on 1 August 2024.

BioMarin plans to use the funds to repay debt, repurchase notes due in October 2018, as well as for general corporate purposes.

Spectrum Pharmaceuticals plans for a private placement of shares to raise up to $150m.

"Spectrum Pharmaceuticals plans for a private placement of shares to raise up to $150m."

The US-based biopharmaceutical company plans to use the funds towards general corporate purposes.

Chinese pharmaceutical company Orient Pharma plans to issue 21 million common stock shares priced at NT$20 ($D0.6) each to raise NT$425m ($14.06m).

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The company plans to use the funds towards loan repayment and for working capital purposes.